The Comparison of the Gut Microbiome Composition, Serum Inflammatory Markers and Faecal Short‐Chain Fatty Acids Among Individuals With Type 1 and 2 Diabetes Mellitus With Healthy Controls: A Case–Control Study
Endocrinology, Diabetes & Metabolism · 2025
DOI: 10.1002/edm2.70071 ↗At a glance
Vergleichsstudie in Endocrinology, Diabetes & Metabolism, 2025. Written by Hossein Yarmohammadi and 11 co-authors. Institution: Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran. Major MEDLINE topics: Diabetes Mellitus, Type 2, Gastrointestinal Microbiome, Feces, Fatty Acids, Volatile. Cited 13 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Institute for Medical Research Development of Iran.
Topics: Diabetes mellitus
Abstract (original language)
Background
This study aimed to compare the gut microbiome (GM) composition, serum inflammatory markers and faecal short‐chain fatty acids among individuals with type 1 and type 2 diabetes mellitus (DM) and healthy controls.
Methods
This case–control study examined 49 subjects with type 2 DM, 21 with type 1 DM and 40 healthy controls. Blood and faecal samples were collected. Serum inflammatory markers, including CRP, IL‐1β, IL‐6, TNF‐α and IFN‐γ, were measured using enzyme‐linked immunosorbent assays (ELISA). Bacterial populations were quantified using RT‐qPCR and NGS. Faecal metabolites were analysed using gas chromatography.
Results
Simpson's alpha diversity was higher among types 1 and 2 DM than in the control. The frequency of the bacterial genera Gemmiger , Dorea , Collinsella , Escherichia/Shigella , Dialister , Coprococcus , Achromobacter , Intestinimonas and Allisonella in type 2 DM was higher than in the control, and the frequency of the genera Romboutsia and Clostridium was decreased in type 2 DM. The frequency of the Prevotella , Bacteroides and Faecalibacterium genera in type 1 DM was lower than in the other groups. Acetate, propionate and butyrate levels were significantly higher in type 2 DM patients compared to the other groups. Participants with diabetes had significantly higher hs‐CRP, IL1‐β, TNF, IL‐6 and IFG levels compared to the controls. Compared to healthy controls, both T1DM and T2DM patients showed a significant increase in the abundance of the Lactobacillus genus ( p = 0.01) and a decrease in Faecalibacterium ( p = 0.02). Additionally, serum levels of IL‐6 and TNF‐α were significantly elevated in T2DM patients ( p = 0.003 and p = 0.005, respectively). Faecal levels of butyrate were significantly reduced in both diabetic groups compared to the controls ( p = 0.004).
Conclusion
By determining the GM alterations in patients with diabetes, interventional strategies could be designed to modulate the GM composition as an adjunctive therapy in diabetes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
- Health Research Center, Chamran Hospital, Tehran, Iran.
- Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
- Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
ORCID profiles: Hossein Yarmohammadi, Masood Soltanipur, Mahdi Rezaei, Hanieh-Sadat Ejtahed, Maedeh Raei, Alireza Razavi, Seyed Mohsen Mirhosseini, Mehrangiz Zangeneh, Delaram Doroud, Abolfazl Fateh, Seyedalireza Seyed Siamdoust, Seyed Davar Siadat
Funding
- National Institute for Medical Research Development of Iran
Cite
APA
Yarmohammadi, H., Soltanipur, M., Rezaei, M., Ejtahed, H. S., Raei, M., Razavi, A., Mirhosseini, S. M., Zangeneh, M., Doroud, D., Fateh, A., Seyed Siamdoust, S., & Siadat, S. D. (2025). The Comparison of the Gut Microbiome Composition, Serum Inflammatory Markers and Faecal Short‐Chain Fatty Acids Among Individuals With Type 1 and 2 Diabetes Mellitus With Healthy Controls: A Case–Control Study. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70071
Vancouver
Yarmohammadi H, Soltanipur M, Rezaei M, Ejtahed HS, Raei M, Razavi A, et al. The Comparison of the Gut Microbiome Composition, Serum Inflammatory Markers and Faecal Short‐Chain Fatty Acids Among Individuals With Type 1 and 2 Diabetes Mellitus With Healthy Controls: A Case–Control Study. Endocrinology, Diabetes & Metabolism. 2025. doi:10.1002/edm2.70071
BibTeX
@article{Yarmohammadi2025,
author = {Yarmohammadi, Hossein and Soltanipur, Masood and Rezaei, Mahdi and Ejtahed, Hanieh-Sadat and Raei, Maedeh and Razavi, Alireza and Mirhosseini, Seyed Mohsen and Zangeneh, Mehrangiz and Doroud, Delaram and Fateh, Abolfazl and Seyed Siamdoust, Seyedalireza and Siadat, Seyed Davar},
title = {The Comparison of the Gut Microbiome Composition, Serum Inflammatory Markers and Faecal Short‐Chain Fatty Acids Among Individuals With Type 1 and 2 Diabetes Mellitus With Healthy Controls: A Case–Control Study},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2025},
doi = {10.1002/edm2.70071}
}
EUVIMED